Search Results 651-660 of 16984 for pharmacogenetics

  1. The Use of the Cerebral Oximetry for Patients Undergoing Dynamic Computed Tomography Myelography under General Anesthesia - Mayo Clinic

    The purpose of this study is to: Prospectively characterize the dynamic systemic hemodynamic changes that occur during dynamic CT myelography. Prospectively ...

  2. Kidney Disease Discovery - Mayo Clinic Research

    The Harris lab is investigating several types of kidney conditions. Autosomal dominant polycystic kidney disease (ADPKD). Our studies of ADPKD focus on genetic ...

  3. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  4. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  5. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...

  6. clinicaltrials gov.

  7. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment. Participation ...

  8. Medical Research & Education - Mayo Clinic News Network

    The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...

  9. A Study to Determine if Differences in the Microbe Environment of the Intestines Connects to the Effects of Obesity on Intestinal Stem Cells - Mayo Clinic

    About this study. New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous.

  10. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...